Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Local treatment of HVJ-E with T cell costimulatory molecule stimulation elicits systemic anti-tumor effects.
Ishibashi A, Li Y, Hisatomi Y, Ohta N, Uegaki Y, Tanemura A, Ohashi R, Kitamura K, Saga K, Yoshimura Y, Inubushi S, Ishida K, Iwabuchi S, Hashimoto S, Kiyohara E, Yagita H, Kaneda Y, Nimura K. Ishibashi A, et al. Among authors: kiyohara e. Mol Ther Oncol. 2024 Oct 10;32(4):200893. doi: 10.1016/j.omton.2024.200893. eCollection 2024 Dec 19. Mol Ther Oncol. 2024. PMID: 39534532 Free PMC article.
Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study.
Kiyohara E, Tanemura A, Nishioka M, Yamada M, Tanaka A, Yokomi A, Saito A, Sakura K, Nakajima T, Myoui A, Sakurai T, Kawakami Y, Kaneda Y, Katayama I. Kiyohara E, et al. Cancer Immunol Immunother. 2020 Jun;69(6):1131-1140. doi: 10.1007/s00262-020-02509-8. Epub 2020 Feb 11. Cancer Immunol Immunother. 2020. PMID: 32047956 Free PMC article. Clinical Trial.
A phase I dose-escalation, safety/tolerability, and preliminary efficacy study of the intratumoral administration of GEN0101 in patients with advanced melanoma.
Kiyohara E, Tanemura A, Sakura K, Nakajima T, Myoui A, Yamazaki N, Kiyohara Y, Katayama I, Fujimoto M, Kaneda Y. Kiyohara E, et al. Among authors: kiyohara y. Cancer Immunol Immunother. 2022 Aug;71(8):2041-2049. doi: 10.1007/s00262-021-03122-z. Epub 2022 Jan 5. Cancer Immunol Immunother. 2022. PMID: 34984539 Free PMC article. Clinical Trial.
Case of minocycline-induced hyperpigmentation mimicking angiosarcoma.
Yokoi K, Tanemura A, Takafuji M, Hanaoka Y, Kiyohara E, Fujimoto M. Yokoi K, et al. Among authors: kiyohara e. J Dermatol. 2019 Nov;46(11):e414-e416. doi: 10.1111/1346-8138.14995. Epub 2019 Jun 25. J Dermatol. 2019. PMID: 31237715 No abstract available.
Use of a combination of oral psoralen, ultraviolet A and interferon-γ for the treatment of mycosis fungoides during pregnancy, which probably evoked CD8+ CD30+ lymphoproliferative disorder.
Tonomura K, Kiyohara E, Nakanishi Y, Tanemura A, Arase N, Nakagawa Y, Fujimoto M. Tonomura K, et al. Among authors: kiyohara e. J Dermatol. 2021 Jan;48(1):e17-e18. doi: 10.1111/1346-8138.15628. Epub 2020 Oct 5. J Dermatol. 2021. PMID: 33017062 No abstract available.
63 results